ARHGAP1 and breast carcinoma: Breast cancer cells also secrete exosomes loaded with miR-940, which enhance the osteogenic differentiation potential of mesenchymal stem cells (MSCs) by suppressing the expression of Rho GTPase-activating protein 1 (ARHGAP1), thereby inhibiting the activation of the RhoA/ROCK signaling pathway.